PEREGRINE PHARMACEUTICALS INC (PPHM) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 159 transactions totaling $893.9K, demonstrating a bullish sentiment with $893.9K in net insider flow. The most recent transaction on Oct 31, 2017 involved a transaction of 1,398 shares valued at $5.4K.
No significant insider buying has been recorded for PPHM in the recent period.
No significant insider selling has been recorded for PPHM in the recent period.
Based on recent SEC filings, insider sentiment for PPHM is bullish with an Insider Alignment Score of 100/100 and a net flow of $893.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at PEREGRINE PHARMACEUTICALS INC (PPHM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading PPHM stock, having executed 159 transactions in the past 90 days. The most active insider is Eric S. Swartz (Executive), who has made 49 transactions totaling $570.8K.
Get notified when executives and directors at PPHM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 31, 2017 | W. King Steven | Executive | Other | 1,398 | $3.87 | $5.4K | |
| Oct 31, 2017 | Shan Joseph | Executive | Other | 2,747 | $3.87 | $10.6K | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 4,993 | $4.49 | $22.4K | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 200 | $4.48 | $896 | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 1,800 | $4.49 | $8.1K | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 300 | $4.49 | $1.3K | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 201 | $4.49 | $902 | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 5,340 | $4.49 | $24.0K | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 35,966 | $4.51 | $162.2K | |
| Oct 27, 2017 | R. Bamforth Mark | Executive | Purchase | 1,200 | $4.51 | $5.4K | |
| Apr 28, 2017 | W. King Steven | Executive | Other | 19,941 | $0.27 | $5.4K | |
| Apr 28, 2017 | J. Lytle Paul | Executive | Other | 37,389 | $0.27 | $10.1K | |
| Apr 28, 2017 | Shan Joseph | Executive | Other | 39,177 | $0.27 | $10.6K | |
| Oct 31, 2016 | Pm Fussey Shelley | Executive | Other | 25,433 | $0.29 | $7.4K | |
| Oct 31, 2016 | W. King Steven | Executive | Other | 18,826 | $0.29 | $5.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 78 | $893.9K | 76.4% |
Other(J) | 42 | $248.5K | 21.2% |
Exercise(M) | 2 | $27.0K | 2.3% |
Award(A) | 21 | $0 | 0.0% |
Disposition(D) | 16 | $0 | 0.0% |
Insiders at PEREGRINE PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 11 insiders making 159 transactions totaling $893.9K in purchases versus $0 in sales, the net buying activity of $893.9K signals strong executive confidence. Eric S. Swartz (Executive) leads the buying activity with $570.8K in transactions across all time.